|
| Press Releases |
|
 |
|
| Wednesday, September 8, 2021 |
|
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药，一家专注于肿瘤治疗领域的创新型全球生物制药公司，今日宣布其口服泛PI3K抑制剂buparlisib（AN2025）、口服EP4拮抗剂（AN0025）与PD-L1抑制剂atezolizumab（阿替利珠单抗）三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。
more info >> |
|
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
| 阿諾醫藥，一家專注於腫瘤治療領域的創新型全球生物製藥公司，今日宣佈其口服泛PI3K抑制劑buparlisib（AN2025）、口服EP4拮抗劑（AN0025）與PD-L1抑制劑atezolizumab（阿替利珠單抗）三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
| Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
| Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Peer To Peer Network (OTC: PTOP) Targets Revenue Inflection Point with MOBICARD 1.8 Launch Expected Within 30 Days
Apr 25, 2026 07:03 HKT/SGT
|
|
|
EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets
Apr 24, 2026 20:00: JST
|
|
|
EQIBank expands global, regulated Banking-as-a-Service platform for cross-border banking across fiat and digital assets
Apr 24, 2026 19:00 HKT/SGT
|
|
|
FastX Announces Its Launch, a New Generation Global Trading Exchange
Apr 24, 2026 13:00: JST
|
|
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Apr 24, 2026 12:05 HKT/SGT
|
|
|
FastX Announces Its Launch, a New Generation Global Trading Exchange
Apr 24, 2026 12:00 HKT/SGT
|
|
|
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
Apr 23, 2026 23:00: JST
|
|
|
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
Apr 23, 2026 22:00 HKT/SGT
|
|
|
Smart Lighting Expo and Lighting Fair conclude successfully
Apr 23, 2026 20:33: JST
|
|
|
Sisel International Appoints Pamela Ferry as General Manager of Australia and New Zealand to Support Regional Expansion
Apr 23, 2026 20:00: JST
|
|
|
康哲藥業：1類新藥MG-K10季節性過敏性鼻炎適應症NDA獲受理
Apr 23, 2026 19:48 HKT/SGT
|
|
|
康哲药业：1类新药MG-K10季节性过敏性鼻炎适应症NDA获受理
Apr 23, 2026 19:48 HKT/SGT
|
|
|
Smart Lighting Expo and Lighting Fair conclude successfully
Apr 23, 2026 19:33 HKT/SGT
|
|
|
GA Ventures Ltd 宣布正式推出 FastX：新一代全球交易交易所
Apr 23, 2026 19:12 HKT/SGT
|
|
|
FastX Launching, a New Generation Global Trading Exchange
Apr 23, 2026 19:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
